Despite challenges, new advances in stem cell biology and genetic engineering show potential for better cell replacement therapies, say experts in a special supplement to JPD Cell replacemen... Read more
NIAID-funded study could offset harsh effects of antibiotics. Researchers at Memorial Sloan Kettering Cancer Center have shown that autologous fecal microbiota transplantation (auto-FMT) is... Read more
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer ce... Read more
Novel three-step pretargeted radioimmunotherapy offers safe, effective treatment Researchers at Memorial Sloan Kettering Cancer Center in New York City and Massachusetts Institute of Technol... Read more
New findings published in Nature Chemical Biology show promise for finding new solutions to treat lung cancer and other deadly diseases. Kentucky continues to lead the nation in incidence an... Read more
Anti-cancer strategies generally involve killing off tumor cells. However, cancer cells may instead be coaxed to turn back into normal tissue simply by reactivating a single gene, according... Read more
US researchers have revealed(link is external) the identity of molecules on the surface of cancer cells which allow the body’s immune system to identify and destroy them. The research... Read more
Cancerous brain tumors are notorious for growing back despite surgical attempts to remove them — and for leading to a dire prognosis for patients. But scientists are developing a new way to... Read more
Cell Therapy Shows Remarkable Ability to Eradicate Cancer in Clinical Study Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the mos... Read more
Placement of copper objects in intensive care unit (ICU) hospital rooms reduced the number of healthcare-acquired infections (HAIs) in patients by more than half Placement of copper objects... Read more
Eleven scientists became multimillionaires this morning when they were named the first winners of the new Breakthrough Prize in Life Sciences. Each researcher, whose specialties include gene... Read more
The U.S. Food and Drug Administration (FDA) has approved the first clinical trial in humans of a new technology: Cornell Dots, brightly glowing nanoparticles that can light up cancer cells i... Read more
